Skip to main content

Life Sciences

Trending: Using EHR Data To Determine Site/Study Feasibility



According to an article in Clinical Leader that featured Bayer Healthcare’s VP Global Strategy & Development Advisor, by evaluating certain criteria against patient populations, electronic health record (EHR) systems can help sponsors determine trial feasibility and shape better study protocols. This can reduce the number of amendments, which can cost anywhere from $300,000 to $500,000 each. 

EHR data might also dissuade sponsors from attempting certain trials, due the lack of specific patient populations. This in itself could prevent companies from having to initiate study start-up activities, including technology enablement, site training, and shipping products, thereby reducing the overall cost of drug development.

Expect to see a spike in EHR investments over the next few years, especially integrations between EHR and electronic data capture (EDC) systems.

To learn about other new trends that we can also expect to see in 2016, fill out the form below or click here.

Leave a Reply

Your email address will not be published. Required fields are marked *

This site uses Akismet to reduce spam. Learn how your comment data is processed.

Eugene Sefanov

Director, Industry and Regional Marketing

More from this Author

Follow Us